Results 201 to 210 of about 1,588,451 (244)
Correction: PRRX1 upregulates PD-L1 in human mesenchymal stem cells. [PDF]
Osawa T +4 more
europepmc +1 more source
CPAN integrates celastrol‐driven oxidative stress with Pt(IV)‐induced DNA damage to couple ferroptosis with caspase‐independent pyroptosis. Celastrol disrupts the GSH/GPX4 axis and promotes lipid peroxidation, while Pt(IV)‐associated PARP/PARylation signaling facilitates full‐length GSDME oligomerization.
Huirong Li +12 more
wiley +1 more source
PD-L1 expression in tissues of cats with naturally occurring feline infectious peritonitis. [PDF]
Zabiegala A, Kim Y, Long M, Chang KO.
europepmc +1 more source
Vanadium Oxide Nanoregulator Modulates cGAS‐STING Pathway‐Associated Immune Dysregulation in Sepsis
This work reveals a pathogenic mitochondrial DNA‐cGAS‐STING inflammatory axis in septic patients and demonstrates that vanadium oxide nanospheres with shape‐optimized catalytic surfaces can shut down this pathway by blocking mitochondrial DNA release.
Tian Zhou +8 more
wiley +1 more source
PRKX-mediated stabilization of PD-L1 characterizes an immunosuppressive gastric cancer subtype. [PDF]
Wang Q +10 more
europepmc +1 more source
Sustained co‐delivery of insulin autoantigen and low‐dose interleukin‐2 from an injectable hydrogel depot established a transient tolerogenic niche that expanded regulatory T cells and delayed median diabetes onset from 20 to >40 weeks in non‐obese diabetic mice.
Leslee T. Nguyen +16 more
wiley +1 more source
Immunotherapy With Anti-PD-1 Versus Anti-PD-L1 in SCLC: A Comprehensive Retrospective Analysis. [PDF]
Yang R, Gan J, Yang L, Chen B, Li W.
europepmc +1 more source
ABSTRACT Immune checkpoint blockade (ICB) has transformed the treatment of mismatch repair‐deficient (dMMR) colorectal cancer but produces no meaningful benefit in advanced mismatch repair‐proficient (pMMR) disease. In the neoadjuvant setting, however, pathological responses have been reported in a subset of pMMR tumors, suggesting that clinical ...
Kimihiro Yamashita +4 more
wiley +1 more source

